Allarity Therapeutics, Inc. Common Stock (ALLR) is a publicly traded Healthcare sector company. As of September 30, 2026, ALLR trades at $1.02 with a market cap of $15.41M and a P/E ratio of -1.25. ALLR moved +5.69% today. Year to date, ALLR is -10.64%; over the trailing twelve months it is -39.30%. Its 52-week range spans $0.61 to $2.35. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces ALLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALLR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ALLR recently traded at $1.02. Market cap is $15.41M. P/E ratio is -1.25. Revenue is $320.00K.
| Metric | Value |
|---|---|
| Price | $1.02 |
| Market Cap | $15.41M |
| P/E Ratio | -1.25 |
| EPS | $-0.78 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.35 |
| 52-Week Low | $0.61 |
| Volume | 18.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $320.00K |
| Net Income | $-11.23M |
| Gross Margin | 0.00% |
1 analysts cover ALLR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.